Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease with a prevalence of approximately 1 in 1000. Over the last 30 years, advances in treatment such as use of corticosteroids and immunosuppressants have improved life expectancy and quality of life for patients with lupus and the ke...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakshi, Jyoti, Segura, Beatriz Tejera, Wincup, Christopher, Rahman, Anisur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244922/
https://www.ncbi.nlm.nih.gov/pubmed/28853005
http://dx.doi.org/10.1007/s12016-017-8640-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244922/
https://www.ncbi.nlm.nih.gov/pubmed/28853005
http://dx.doi.org/10.1007/s12016-017-8640-5

Ejemplares similares